Detailed information of SRF

Dataset summary

TF Name: SRF Species: Mus musculus
Cell-type/Tissue: BMDM (bone marrow-derived macrophages) Condition/Source: Lipid A stimulation for 15 minutes
JASPAR ID: MA0083.3 Collections: Permissive Robust
References: GEO GSE67343 GSM1645125 GTRD EXP034714 PUBMED 26924576

External links

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA0083.3 17.5 143 88.8 -48.5060348015908

56 datasets found for the same TF (SRF) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
SRF cornea Dstn1-corn mutant Permissive Robust Mus musculus GSE54209 ... MA0083.3
SRF NIH 3T3 (embryonic fibroblasts) Latrunculin B 0.3uM Permissive Robust Mus musculus GSE45888 ... MA0083.3
SRF NIH 3T3 (embryonic fibroblasts) U0126 10uM Permissive Robust Mus musculus GSE45888 ... MA0083.3
SRF BMDM (bone marrow-derived macrophages) Lipid A stimulation for 0 minutes Permissive Robust Mus musculus GSE67343 ... MA0083.3
SRF BMDM (bone marrow-derived macrophages) Lipid A stimulation for 30 minutes Permissive Robust Mus musculus GSE67343 ... MA0083.3
SRF BMDM (bone marrow-derived macrophages) Lipid A stimulation for 60 minutes Permissive Robust Mus musculus GSE67343 ... MA0083.3
SRF BMDM (bone marrow-derived macrophages) Lipid A stimulation for 120 minutes Permissive Robust Mus musculus GSE67343 ... MA0083.3
SRF embryonic fibroblasts after 12 min heat shock Permissive Mus musculus GSE71708 ... MA0083.3
SRF embryonic fibroblasts after 60 min heat shock Permissive Mus musculus GSE71708 ... MA0083.3
SRF embryonic fibroblasts 12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes Permissive Robust Mus musculus GSE75667 ... MA0083.3
SRF embryonic fibroblasts TCF KO Permissive Robust Mus musculus GSE75667 ... MA0083.3
SRF embryonic fibroblasts TCF KO; 12-O-tetradecanoyl phorbol-13-acetate (Sigma TPA, 50 ng/ml) for 30 minutes Permissive Robust Mus musculus GSE75667 ... MA0083.3
SRF A-673 clone Asp114 (Ewing sarcoma) no doxycycline, serum-induction Permissive Homo sapiens GSE92738 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Passage: p1 Permissive Robust Mus musculus GSE112417 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Passage: p10 Permissive Robust Mus musculus GSE112417 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Treatment: infected with shNT for 3 days Permissive Robust Mus musculus GSE112417 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Treatment: infected with shNT for 3 days Permissive Robust Mus musculus GSE112417 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Treatment: infected with sh2AZ for 3 days Permissive Mus musculus GSE112417 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Treatment: infected with sh2AZ for 3 days Permissive Robust Mus musculus GSE112417 ... MA0083.3
SRF differentiated neural progenitor cells Source: Neural progenitor cells expressing no ectopic gene Permissive Robust Mus musculus GSE106319 ... MA0083.3
SRF differentiated neural progenitor cells Treatment: transgene of Srf was introduced retrovirally Source: Neural progenitor cells overexpressing Srf Permissive Robust Mus musculus GSE106319 ... MA0083.3
SRF fetal liver Source: Hepatoblasts (expressing no ectopic gene) Permissive Robust Mus musculus GSE106319 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: No treatment, no TPA Source: HEL-iMKL1 cells Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: No treatment, no TPA Source: HEL-iMKL1 cells Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF HEL (Erythro Leukemia) Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed Permissive Robust Homo sapiens GSE112265 ... MA0083.3
SRF 10T1/2 Treatment: sictrl; Background cell line: C3H/HeN; Permissive Robust Mus musculus GSE40369 ... MA0083.3
SRF ILC2 (type 2 Innate lympoid cells) Treatment: siMed23; Background cell line: C3H/HeN; Genotype: knockdown Med23; Permissive Robust Mus musculus GSE40369 ... MA0083.3
SRF induced pluripotent stem cells Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus; Permissive Robust Mus musculus GSE120399 ... MA0083.3
SRF induced pluripotent stem cells Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus; Permissive Robust Mus musculus GSE120399 ... MA0083.3
SRF induced pluripotent stem cells Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus; Permissive Robust Mus musculus GSE120399 ... MA0083.3
SRF induced pluripotent stem cells Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus; Permissive Robust Mus musculus GSE120399 ... MA0083.3
SRF GM12878 (female B-cells lymphoblastoid cell line) Permissive Robust Homo sapiens ENCSR000BGE MA0083.3
SRF WA01 (H1, human embryonic stem cells) Permissive Robust Homo sapiens ENCSR000BIV MA0083.3
SRF K562 (myelogenous leukemia) Permissive Robust Homo sapiens ENCSR000BLK MA0083.3
SRF HepG2 (hepatoblastoma) Permissive Robust Homo sapiens ENCSR000BLV MA0083.3
SRF GM12878 (female B-cells lymphoblastoid cell line) Permissive Robust Homo sapiens ENCSR000BMI MA0083.3
SRF HCT-116 (colon carcinoma) Permissive Robust Homo sapiens ENCSR000BSC MA0083.3
SRF Ishikawa (endometrial adenocarcinoma) Permissive Robust Homo sapiens ENCSR000BTD MA0083.3
SRF MCF7 (Invasive ductal breast carcinoma) Permissive Robust Homo sapiens ENCSR000BVA MA0083.3
SRF HL-1 (cardiac muscle cells) Permissive Mus musculus GSE19065 ... MA0083.3
SRF myocytes Permissive Robust Mus musculus ENCSR000AIM ... MA0083.3
SRF HL-1 (cardiac muscle cells) Permissive Robust Mus musculus GSE21529 ... MA0083.3
SRF cornea Permissive Robust Mus musculus GSE54209 ... MA0083.3
SRF embryonic fibroblasts Permissive Mus musculus GSE71708 ... MA0083.3
SRF HUES64 (embryonic stem cells) Permissive Homo sapiens GSE61475 ... MA0083.3
SRF HUES64 (embryonic stem cells) Permissive Homo sapiens GSE61475 ... MA0083.3
SRF HUES64 (embryonic stem cells) Permissive Homo sapiens GSE61475 ... MA0083.3
SRF HUES64 (embryonic stem cells) Permissive Homo sapiens GSE61475 ... MA0083.3
SRF HUES64 (embryonic stem cells) Permissive Homo sapiens GSE61475 ... MA0083.3
SRF embryonic fibroblasts Permissive Robust Mus musculus GSE75667 ... MA0083.3
SRF primary vascular smooth muscle cell (C57BL/6 mice) Permissive Mus musculus GSE112417 ... MA0083.3